FinLab AG

  • WKN: 121806
  • ISIN: DE0001218063
  • Land: Deutschland

Nachricht vom 23.03.2021 | 09:00

FinLab AG: FinLab publishes 2020 annual financial report

DGAP-News: FinLab AG / Key word(s): Annual Report/Annual Results
23.03.2021 / 09:00
The issuer is solely responsible for the content of this announcement.

  • Positive results and significant increase in NAV
  • Herbert Seuling appointed to the Supervisory Board

Frankfurt am Main, March 23, 2021 - FinLab AG (WKN 121806, ISIN DE0001218063, ticker A7A.GR) today publishes its figures for the 2020 financial year.

FinLab has developed positively in the past fiscal year. A total result of EUR 25.8 million (PY: EUR 36.6 million) and a net result for the period of EUR 6.1 million (PY: EUR 39.5 million) were achieved in accordance with International Financial Reporting Standards (IFRS). According to the German Commercial Code (HGB), the company achieved a net income of EUR 0.3 million (PY: EUR -1.5 million).

FinLab's net asset value (NAV) per share increased from EUR 27.12/share to EUR 32.02/share as of the balance sheet date. The equity of the company according to IFRS amounts to EUR 168.6 million (PY: EUR 142.8 million). The stable equity ratio is 97.4% (PY: 97.9%). As of the balance sheet date, the Company had cash and cash equivalents of EUR 6.1 million (PY: EUR 6.8 million).

After more than ten years of service, Dr. Friedrich Schmitz resigned from the Supervisory Board of FinLab AG for personal reasons. Mr. Herbert Seuling has succeeded him by court appointment as of March 16, 2021. FinLab looks forward to working with Mr. Seuling and would like to thank Dr. Schmitz for his many years of support and commitment to FinLab AG.

The Annual Financial Report 2020 will be published at www.FinLab.de in the Investor Relations section.


About FinLab AG:
Stock market listed company FinLab AG (WKN 121806 / ISIN DE0001218063 / ticker symbol: A7A.GR) is one of the first and largest company builders and investors focused on the Financial Services Technologies ("FinTech") sector in Europe. FinLab focuses on developing German FinTech startups and providing venture capital for their financial needs, whereby in each case the aim is a long-term participation and ongoing support of the investment. FinLab also invests globally, as part of venture rounds, in FinTech companies, primarily in the USA and Asia.


Press contact:
FinLab AG:
investor-relations@finlab.de
www.finlab.de
Phone: +49 69 719 12 80 0



23.03.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Event im Fokus

Termine 2021

10. Juni 2021:Fachkonferenz Immobilien

14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure

13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie

10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix

„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“

GBC-Fokusbox

Kaufen: Aspermont Limited hat Turnaround abgeschlossen

Aspermont Limited ist der weltweit führende Anbieter von Business-to-Business-Medien (B2B) für den Rohstoffsektor. Mit einem neuen Management hat das Unternehmen seit 2016 den erfolgreichen Turnaround von einem traditionellen Medienunternehmen zu einem digitalen B2B-XaaS-Geschäftsmodell umgesetzt. Das Unternehmen hat diesen Turnaround im GJ 2020 abgeschlossen, als es sein erstes positives EBITDA-Ergebnis verzeichnete. Auf der Grundlage unseres DCF-Modells haben wir ein Kursziel von 0,09 AUD (0,06 Euro) pro Aktie ermittelt und vergeben das Rating KAUFEN.

News im Fokus

Vonovia SE: Deutschlands führendes Wohnungsunternehmen baut erneuerbare Energie weiter aus: Vonovia bestückt 30.000 Dächer mit Photovoltaik-Anlagen

21. September 2021, 09:58

Aktueller Webcast

Stealth BioTherapeutics

Cantor Global Healthcare Conference Fireside Chat

30. September 2021

Aktuelle Research-Studie

MPH Health Care AG

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH): Buy

20. September 2021